DK1216091T3 - Process for Encapsulating Active Substances by Coacervation of Polymers in Non-Chlorinated Solvent - Google Patents

Process for Encapsulating Active Substances by Coacervation of Polymers in Non-Chlorinated Solvent

Info

Publication number
DK1216091T3
DK1216091T3 DK00958741T DK00958741T DK1216091T3 DK 1216091 T3 DK1216091 T3 DK 1216091T3 DK 00958741 T DK00958741 T DK 00958741T DK 00958741 T DK00958741 T DK 00958741T DK 1216091 T3 DK1216091 T3 DK 1216091T3
Authority
DK
Denmark
Prior art keywords
coacervation
active principle
solvent
hardening
polymers
Prior art date
Application number
DK00958741T
Other languages
Danish (da)
Inventor
Joel Richard
Jean-Pierre Benoit
Elvire Fournier
Sonia Liu
Original Assignee
Mainelab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mainelab filed Critical Mainelab
Application granted granted Critical
Publication of DK1216091T3 publication Critical patent/DK1216091T3/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/08Simple coacervation, i.e. addition of highly hydrophilic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes

Abstract

The invention concerns a method for microencapsulation of an active principle by coacervation which consists in controlled desolvation or coacervation of a polymer dissolved in an organic solvent containing said active principle, said coacervation being induced by adding a non-solvent causing the polymer to be deposited at the surface of the active principle, and by hardening the polymer deposit by adding a hardening agent, said hardening being leading to the formation of a continuous film coating the active principle. The invention is characterised in that the solvent is selected among ethyl acetate, N-methylpyrrolidone, methylethylacetone and acetic acid. The non-solvent is advantageously an alcohol comprising two to five carbon atoms and the hardening agent being for instance selected among water, alcohols comprising four carbon atoms and mixtures thereof.
DK00958741T 1999-08-27 2000-08-25 Process for Encapsulating Active Substances by Coacervation of Polymers in Non-Chlorinated Solvent DK1216091T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910854A FR2797784B1 (en) 1999-08-27 1999-08-27 PROCESS FOR THE ENCAPSULATION OF ACTIVE MATERIALS BY COACERVATION OF POLYMERS IN NON-CHLORINE ORGANIC SOLVENT

Publications (1)

Publication Number Publication Date
DK1216091T3 true DK1216091T3 (en) 2004-07-12

Family

ID=9549384

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00958741T DK1216091T3 (en) 1999-08-27 2000-08-25 Process for Encapsulating Active Substances by Coacervation of Polymers in Non-Chlorinated Solvent

Country Status (18)

Country Link
EP (1) EP1216091B9 (en)
JP (1) JP5217070B2 (en)
KR (1) KR100661093B1 (en)
CN (1) CN1317064C (en)
AT (1) ATE261338T1 (en)
AU (1) AU776959B2 (en)
CA (1) CA2382697C (en)
DE (1) DE60008894T2 (en)
DK (1) DK1216091T3 (en)
ES (1) ES2215718T3 (en)
FR (1) FR2797784B1 (en)
HU (1) HU228747B1 (en)
IL (2) IL148316A0 (en)
MX (1) MXPA02002250A (en)
NO (1) NO322106B1 (en)
PT (1) PT1216091E (en)
WO (1) WO2001015799A1 (en)
ZA (1) ZA200201543B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1404516A2 (en) 2000-12-13 2004-04-07 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US6767637B2 (en) 2000-12-13 2004-07-27 Purdue Research Foundation Microencapsulation using ultrasonic atomizers
EP1343480B2 (en) 2000-12-21 2016-02-17 Alrise Biosystems GmbH Induced phase transition method for the production of microparticles containing hydrophobic active agents
FR2824756B1 (en) * 2001-05-16 2005-07-08 Mainelab MICROCAPSULES BASED ON PLANT PROTEINS
FR2832312B1 (en) * 2001-11-21 2004-01-16 Inst Nat Sante Rech Med PROCESS FOR THE PREPARATION OF MICROPARTICLES WITHOUT TOXIC SOLVENT, MICROPARTICLES OBTAINED ACCORDING TO THIS PROCESS, USES AND PHARMACEUTICAL COMPOSITIONS
US9480631B2 (en) 2008-11-10 2016-11-01 Colgate-Palmolive Company Shelf stable capsules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
JPS5966425A (en) * 1982-10-08 1984-04-14 Mitsui Toatsu Chem Inc Preparation of fine particle using biodegradable polymer
JPS62213840A (en) * 1986-03-14 1987-09-19 Snow Brand Milk Prod Co Ltd Method for drying microcapsule
JPS6365945A (en) * 1986-09-05 1988-03-24 Eisai Co Ltd Preparation of microcapsule
US5234520A (en) * 1987-03-20 1993-08-10 Morgan Adhesives Co. Method of making an adhesive construction
JP2670680B2 (en) * 1988-02-24 1997-10-29 株式会社ビーエムジー Polylactic acid microspheres containing physiologically active substance and method for producing the same
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
JP3114245B2 (en) * 1991-06-03 2000-12-04 藤沢薬品工業株式会社 Method for producing sustained-release preparation
DK0674506T3 (en) * 1992-12-02 2001-01-08 Alkermes Inc Controlled release growth hormone-containing microspheres
ES2172574T5 (en) * 1993-11-19 2012-11-29 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
ES2236700T3 (en) * 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-MICROENCAPSULATED BENZAZOLS.
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent

Also Published As

Publication number Publication date
NO20020881L (en) 2002-04-25
ATE261338T1 (en) 2004-03-15
CA2382697A1 (en) 2001-03-08
FR2797784B1 (en) 2001-11-30
PT1216091E (en) 2004-08-31
IL148316A0 (en) 2002-09-12
HU0203199D0 (en) 2002-10-28
CN1317064C (en) 2007-05-23
CA2382697C (en) 2009-05-05
ES2215718T3 (en) 2004-10-16
HU228747B1 (en) 2013-05-28
FR2797784A1 (en) 2001-03-02
EP1216091B9 (en) 2005-01-19
WO2001015799A1 (en) 2001-03-08
JP2003508195A (en) 2003-03-04
MXPA02002250A (en) 2003-08-20
KR20020046284A (en) 2002-06-20
ZA200201543B (en) 2002-11-27
AU776959B2 (en) 2004-09-30
NO322106B1 (en) 2006-08-14
DE60008894D1 (en) 2004-04-15
IL148316A (en) 2006-10-31
EP1216091A1 (en) 2002-06-26
AU7016800A (en) 2001-03-26
KR100661093B1 (en) 2006-12-22
CN1371301A (en) 2002-09-25
EP1216091B1 (en) 2004-03-10
HUP0203199A2 (en) 2003-03-28
NO20020881D0 (en) 2002-02-22
JP5217070B2 (en) 2013-06-19
DE60008894T2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
ATE405623T1 (en) TOPOLOGICALLY STRUCTURED POLYMER COATING
EP1251013A3 (en) Inkjet recording sheet
PL1784232T3 (en) Biologically-active adhesive articles and methods of manufacture
DE50103340D1 (en) METHOD FOR PRODUCING CAPSULES CONTAINING ACTIVE SUBSTANCES WITH ULTRA-THIN WALL LAYER
PE20060335A1 (en) PROLINA CCI-779, ITS PRODUCTION AND ENZYME SYNTHESIS OF TWO STAGES OF PROLINA CCI-779 AND CCI-779
EP1166866A3 (en) Encapsulated chemicals for use in controlled time release applications
TW200605963A (en) Coating apparatus and coating method
ATE290038T1 (en) SOLVENT RESISTANT LIGHT SENSITIVE COMPOSITIONS
DE60041704D1 (en) IONS
ATE393623T1 (en) A SLOW RELEASE GRANULE PREPARATION CONTAINING AN AMINE DRUG BASED ON PARTICLES WITH A COATED LAYER AND CORRESPONDING PRODUCTION METHOD
DK1216091T3 (en) Process for Encapsulating Active Substances by Coacervation of Polymers in Non-Chlorinated Solvent
EP1103586A3 (en) Coating powders for heat-sensitive substrates
FR2798130B1 (en) COMPOUND, ORGANIC COMPOSITION FOR ANTI-REFLECTIVE FILM AND METHOD FOR FORMING AN ANTI-REFLECTIVE FILM PATTERN
FR2798129B1 (en) COMPOUND, ORGANIC COMPOSITION FOR ANTI-REFLECTIVE FILM AND METHOD FOR FORMING AN ANTI-REFLECTIVE FILM PATTERN
NL1015506A1 (en) Organic anti-reflective coating polymers and process for their preparation.
DE60305307D1 (en) PREPARATION OF SUPER ABSORBENT MATERIAL BY MEANS OF PLASMA MODIFICATION
DK1276705T3 (en) Process for making coated mineral molds
Nordin et al. Enantioselective transesterifications of 2-methyl-1-alcohols catalysed by lipases from Pseudomonas
EP1270204A4 (en) Surface treating of polymer
DE60002128D1 (en) Process for the preparation of phenylalkanes using an EUO structural type catalyst
RU2006114675A (en) SUSPENSIONS OF ANALGETICS WITH CONTROLLED RELEASE
DE602006007968D1 (en) PROCESS FOR PREPARING AN ALDEHYDE-CONTAINING COATING
ATE335403T1 (en) CELLULOSE-BASED FOOD CASING WITH INCREASED ROAD ADHESION AND A METHOD FOR THE PRODUCTION THEREOF
WO2008064734A3 (en) Medicament with controlled release containing galanthamine
DE602005007591D1 (en) MASKED SOLID CARRIER